Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034924.xml
Download PDF
Nuklearmedizin 1978; 17(03): 110-125
DOI: 10.1055/s-0037-1620680
DOI: 10.1055/s-0037-1620680
Originalarbeiten – Original Articles
Time-Dependent Characteristics of Sn-Complexes for Preparing 99mTc-Labelled Radiopharmaceuticals and their Bioavailabilities - a Review
Zeitabhängige Charakteristika komplexer Zinnverbindungen zur Herstellung 99mTc-markierter Radiopharmaka und deren biologische Verfügbarkeit — eine ÜbersichtFurther Information
Publication History
Received:
12 October 1977
Publication Date:
09 January 2018 (online)
A review is made of some of the factors affecting bioavailability of diagnostic 99mTc-radiopharmaceuticals currently used in the practice of nuclear medicine.
Es wird eine Übersicht über eine Reihe von Faktoren gegeben, die die biologische Verfügbarkeit derzeit in der Nuklearmedizin verwendeter diagnostischer 99mTc-markierter Radiopharmaka beeinflussen.
-
References
- 1 Ackerhalt R. E, Blau M, Bakshi S, Sondel J. A. Comparative study of three 99mTc-labelled phosphorus compounds and 18F-fluoride for skeletal imaging. J. nucl. Med 1974; 15: 1153-1157.
- 2 Ajmani S. K, Lerner S. R, Pircher F. J. Bone scan artifact caused by hyperhidrosis. J. nucl. Med 1977; 18: 801-802.
- 3 Arnold R. W, Subramanian G, McAfee J. G, Blair R. J, Thomas F. D. Comparison of 99mTc complexes for renal imaging. J. nucl. Med 1975; 16: 357-367.
- 4 Arzoumanian A, Rosenthall L, Seto H. Clinical comparison of 99mTc-labelled preformed phytate colloid and sulfur colloid. J. nucl. Med 1977; 18: 118-120.
- 5 Atkins H. L, Cardinale K. G, Eckelman W. C, Hauser W, Klopper J. F, Richards P. Evaluation of 99mTc-DTPA prepared by three different methods. Radiology 1971; 98: 674-677.
- 6 Baker R. J, Bellen J. C, Ronai P. M. Technetium-99m-pyridoxylidene glutamate: a new hepatobiliary radiopharmaceutical. I. Experimental aspects. J. nucl. Med 1975; 16: 720-727.
- 7 Bardy A, Fouye H, Gobin R, Bydon J, deTovar G, Panneciere C, Hegesippe M. Technetium-99m labeling by means of stannous pyrophosphate: application to bleomycin and red blood cells. J. nucl. Med 1975; 16: 435-437.
- 8 Bell E. G, McAfee J. G, Subramanian G. Radiopharmaceuticals in pediatrics. In Pediatric Nuclear Medicine. Eds James Jr. A. E., Wagner Jr. H. N., Cooke R. E.. Philadelphia: W. B. Saunders Co; 1974: 84
- 9 Billinghurst M. W. Chromatographic quality control of 99mTc-labelled compounds. J. nucl. Med 1973; 14: 793-797.
- 10 Billinghurst M. W, Palser R. F. Gel chromatography as an analytical tool for 99mTc-radiopharmaceuticals. J. nucl. Med 1974; 15: 722-723.
- 11 Billinghurst M. W, Rampel S. A qualitative method of determining the level of oxidant in a solution of (99mTc) pertechnetate. J. nucl. Med 1977; 18: 744-746.
- 12 Bobinet D. D, Sevrin R, Zurbriggen M. T, Spotter L, Cohen M. B. Lung uptake of 99mTc-sulfur colloid in patients exihibiting presence of Al+3 in plasma. J. nucl. Med 1974; 15: 1220-1222.
- 13 Bowen B. M, Henderson D. N, Kellam J. E, Wood D. E. Technetium99m cysteine - an agent for renal scintigraphy. Amer. J. Hosp. Pharm 1972; 29: 502-505.
- 14 Breslow K, Halpern S. E, Schwartz F. C, Alazraki N. P, Ashburn W. L. Stability studies and tumor uptake of a technetiumtetracycline complex. J. nucl. Med 1974; 15: 987-990.
- 15 Brody K. R, Hosain P, Spencer R. P, Hosain F, Wagner Jr. H. N.. Technetium-99m labelled imidophosphate: an improved bone-scanning radiopharmaceutical. Brit. J. Radiol 1976; 49: 267-269.
- 16 Brunn P. Standardized sterile kits for preparation of 99mTc-labelled albumin, macroalbumin, iron ascorbic acid complex and antimony sulphide colloid. Scand. J. clin. Lab. Invest 1971; 28: 313-323.
- 17 Brunn P, Lingensmith W. C.. III A comment on the possibility of 99mTc-sulfur colloid retention in the lungs. J. nucl. Med 1974; 15: 726-727.
- 18 Byun H. H, Rodman S. G, Chang K. E. Soft-tissue concentration of 99mTc-phosphates associated with injections of iron dextran complex. J. nucl. Med 1976; 17: 375-376.
- 19 Callery P. S, Faith W. C, Loberg M. D, Fields A. T, Harvey E. B, Cooper M. D. Tissue distribution of technetium-99m and carbon-14 labeled N-(2,6-dimethyl phenyl carba-noylmethyl) iminodiacetic acid. J. med. Chem 1976; 19: 962-964.
- 20 Campeau R. J, Gottlieb S, Kallos N. Aortic aneurysms detected by 99mTc-pyrophosphate imaging. J. nucl. Med 1977; 18: 272-273.
- 21 Caride V. J, Taylor W, Cramer J. A, Gottschalk A. Evaluation of liposome - entrapped radioactive tracers as scanning agents. Part. I. Organ distribution of liposome (99mTc-DTPA) in mice. J. nucl. Med 1976; 17: 1067-1072.
- 22 Castronovo Jr. F. D., Callahan R. J. New bone scanning agents 99mTc-labelled-1 -hydroxy-ethylidene-1 - ldisodium phosphonate. J. nucl. Med 1972; 13: 823-827.
- 23 Chandler W. M, Shuck L. D. Effects of tin on pertechne-tate distribution. J. nucl. Med 1975; 16: 690.
- 24 Chaudhuri T. K. Increased hepatic predilection of bone-seeking radiopharmaceuticals in patients with hypercalcemia. Int. J. nucl. Med. Biol 1976; 3: 199-200.
- 25 Chaudhuri T. K. The effect of aluminium and pH on the altered body distribution of 99mTc-EHDP. Int. J. nucl. Med. Biol 1976; 3: 37.
- 26 Chaudhuri T. K. Liver uptake of 99mTc-diphosphonate. Radiology 1976; 119: 485-486.
- 27 Chaudhuri T. K, Chaudhuri T. K, Gulesserian H. P, Christie J. H. Extraosseous non calcified soft-tissue uptake of 99mTc-polyphosphate. J. nucl. Med 1974; 15: 1054-1056.
- 28 Chervu L. R, Lee H. B, Goyal Q, Blaufox M. D. Use of 99mTc-Cu-DTPA complex as a renal function agent. J. nucl. Med 1977; 18: 62-66.
- 29 Cohen Y. Purity criteria and general specifications of radiopharmaceuticals. In: Analytical Control of Radiopharmaceuticals - Proceedings of a panel. IAEA, Vienna 1970, pp. 1-180.
- 30 Cohen Y, Besnard M. Analytical methods of radiopharmaceutical quality control. In Radiopharmaceuticals. Eds Subramanian G., Rhodes B. A., Cooper J. F, Sodd V. J.. New York: Soc. Nucl. Med. Inc.; 1975: 207-227.
- 31 Coleman R. E. Renal colloid localization. J. nucl. Med 1974; 15: 367-368.
- 32 Colombetti L. G, Moerlien S, Patel G. C, Pinsky S. M. Rapid determination of oxidation state of unbound 99mTc and labelling yield in 99mTc-labelled radiopharmaceuticals. J. nucl. Med 1976; 17: 805-809.
- 33 Colombetti L. G, Moerlien S, Pinsky S. Rapid and reliable preparation of macroaggregated albumin suitable for lung scintigraphy. Int. J. nucl. Med. Biol 1975; 2: 180-184.
- 34 Cooper P. A, Zimmer A. M. Radiochemical purity and stability of commercial 99mTc-stannous DTPA kits using a new chromatography technique. J. nucl. Med. Tech 1975; 3: 208-209.
- 35 Counsell R. E, Ice R. D. The design of organ-imaging radiopharmaceuticals. In: Drug Design, Vol. VI. Ed. New York: E. J. Ariens. Academic Press; 1975: 171-259.
- 36 Coupai J. Do colloids cause you problems? A clear solution is’nt in sight. J. nucl. Med 1977; 18: 852-853.
- 37 Davis M. A, Holman B. L, Carmel A. N. Evaluation of radiopharmaceuticals sequestered by acutely damaged myocardium. J. nucl. Med 1976; 17: 911-917.
- 38 Davis M. A, Kaplan M. L, Ahuberg D. S, Cole C. N. A modified Tc-99m phytate colloid for liver-spleen imaging. Int. J. appl. Radiat 1977; 28: 123-130.
- 39 DeLigny C. L, Gelsema W. L, Brunis M. H. The influence of experimental conditions on the efficiency of labeling of human serum albumin with 99mTc using Sn(II) as the reductant. Int. J. appl. Radiat 1976; 27: 351-356.
- 40 Deutsch E, Elder R. C, Lange B. A, Vaal M. J, Lay D. G. Structural characterization of a bridged 99mTc-Sn-dimethyl-glyoxime complex: Implications for the chemistry of 99mTc-radiopharmaceuticals prepared by the Sn(II) reduction of pertechnetate. Proc. nat. Acad. Sci. (Wash.) 1976; 73: 4287-4289.
- 41 Deutsch M. E, Redmond M. L, Mead L. W. Freeze-dried kits for preparing radiopharmaceuticals from 99mTc. In: Radiopharmaceuticals and Labelled Compounds. Proceedings of a Symposium. Vol. 1. IAEA, Vienna: 1973: 189-194.
- 42 Deutsch P, Gunther T, Rohnett M. Dissociation constants of ethane-1-hydroxy-1, 1-diphosphonate (EHDP) and dichloromethylene diphosphonate (C12MDP) for H +, Ca2 +, Mg2+ and Zn2 + . Z. Naturforsch 1976; 31: 661-663.
- 43 Dewanjee M. K, Fliegel C, Treves S, Davis M. A. 99mTc-tetracyclines: preparation and biological evaluation. J. nucl. Med 1974; 15: 176-182.
- 44 Donaldson J. D, Moser W. Pure tin(II) sulfate. J. chem. Soc 1960; 4000-4003.
- 45 Dumortier A. G, Jeghers O. M, Decostre Ph, Fallais C. J. Indirect influence of sodium nitrate on the radiochemical purity of a Tc-sulfur colloid. Int. J. appl. Radiat 1974; 25: 189-191.
- 46 Dunnick J. K, Kriss J. P. Studies of radiopharmaceutical enclosing lipid-protein vesicles found from native plasma components. J. nucl. Med 1977; 18: 183-186.
- 47 Eckelman W, Meinken G, Richards P. Chemical state of 99mTc in biomedical products. J. nucl. Med 1971; 12: 596-600.
- 48 Eckelman W. C, Reba R. C, Kubota H, Stevenson J. S. 99mTc-pyrophosphate for bone imaging. J. nucl. Med 1974; 15: 279-283.
- 49 Eckelman W. C, Richards P. Instant 99mTc-DTPA. J. nucl. Med 1970; 12: 761.
- 50 Eckelman W. C, Richards P. Analytical pitfalls with 99mTc-labelled compounds. J. nucl. Med 1972; 13: 202-204.
- 51 Elson M. E, Shafer R. B. Quality assurance for 99mTc-Sn-pyrophosphate. J. nucl. Med 1976; 17: 918-923.
- 52 Fischer K. C, Shapiro S, Treves S. Visualization of spleen with a bone-seeking radiopharmaceutical in a child with sickle-cell anemia. Radiology 1977; 122: 398.
- 53 Fitzer P. M. 99mTc-polyphosphate concentration in neuroblastoma. J. nucl. Med 1974; 15: 904-906.
- 54 Flesh L. H, Kihm R. H, Ciccio S. S. Radionuclide imaging of aortic involvement in Buerger’s disease. J. nucl. Med 1977; 18: 125-127.
- 55 George E. A, Henry R. E, Donati R. M. Monitoring rejected renal grafts with 99mTc-sulfur colloid (and reply). J. nucl. Med 1976; 17: 939-940.
- 56 Georgen T. K, Alazraki N. P, Halpern S. P, Heath V, Ashburn W. L. “Cold” bone lesions: a newly recognized phenomenon of bone imaging. J. nucl. Med 1974; 15: 1120-1124.
- 57 Gil M. C, Palma T, Radicella R. Electrolytical labeling of 99mTc-radiopharmaceuticals. Int. J. appl. Radiat 1976; 27: 69-72.
- 58 Glenn H. J, Kidwell R. E. Radioactive pharmaceuticals and the concept of stability. In: Radioactive Pharmaceuticals. Proceedings of a Symposium. Eds Andrews G. A, Kniseley R. M, Wagner Jr. H. N.. U.S.A.E.C.; Oak Ridge: 1966: 165-175.
- 59 Goy W, Crowe W. J. Splenic accumulation of 99mTc-di-phosphonate in a patient with sickle cell disease. J. nucl. Med 1976; 17: 1108-1109.
- 60 Hagan P. L, Chauncey Jr. D. M., Halpern S. E, Ayres P. R. 99mTc-thiomalic acid complex: A non-stannous chelate for renal scanning. J. nucl. Med 1977; 18: 353-359.
- 61 Hambright P, Adabi A, Reid J, Maitland D. Rapid spot test for stannous tin levels in 99mTc kits. J. nucl. Med. Tech 1977; 5: 88-89.
- 62 Hambright P, McRae J, Valk P. E, Bearden A. J, Shipley B. A. Chemistry of technetium radiopharmaceuticals I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc. J. nucl. Med 1975; 16: 478-482.
- 63 Haney T. A, Ascanio I, Gigliotti J. A, Gusmano E. A, Bruno G. A. Physical and biological properties of a 99mTc-sul-fur colloid preparation containing disodium edetate. J. nucl. Med 1971; 12: 64-68.
- 64 Harper P. V, Lathrop K. A, Gottschalk A. Pharmacodynamics of some technetium-99m preparations. In: Radioactive Pharmaceuticals Proceedings of a Symposium. Eds Andrews G. A, Kniseley R. M, Wagner Jr. H. N.. U.S.A.E.C.; Oak Ridge: 1966: 335-358.
- 65 Hauser W, Atkins H. L, Nelson K. G, Richards P. Technetium-99m DTPA: A new radiopharmaceutical for brain and kidney scanning. Radiology 1970; 94: 679-684.
- 66 Hawkins L. A, McAlister J. M. The use of 99mTc antimony sulphide colloid for liver scanning: its preparation and some clinical and experimental observations. Brit. J. Radiol 1969; 42: 657-661.
- 67 Heller L, Shafferman A, Davis M. The effecto of gamma irradiation on KTcO4 solutions. In: Israel Atomic Energy Commission - Research Laboratories Annual Report 1975. IA-1321, IAEC, Tel Aviv. 1976: 200
- 68 Higgins C. B, Taketa R. M, Taylor A, Halpern S. E, Ashburn W. L. Renal uptake of 99mTc-sulfur colloid. J. nucl. Med 1974; 15: 564-566.
- 69 Hirsch J. I, Fogel W. M, Fratkin M. J. Locallization of the renal cortical imaging agent 99mTc-Sn-DMSA in the bowel. Radiology 1977; 122: 404.
- 70 Hladik III W. B., Study K. T, Gallagher J. H, Rhodes B. A. Quality control of radiochemical purity by a rapid feedback system. J. nucl. Med. Tech 1977; 3: 94-100.
- 71 Hotte C. E, Ice R. D. Thermaland radiolytic decomposition of 131I-19-iodocholesterol. J. nucl. Med 1974; 15: 38-41.
- 72 Hosain F. Quality control of 99mTc-DTPA by double tracer technique. J. nucl. Med 1974; 15: 442-445.
- 73 Hosain P. Technetium-99m labelled pyrophosphate: a simple and reproducible bone scanning agent. Brit. J. Radiol 1973; 46: 724-728.
- 74 Hosain P, Hosain F. Significance of femur and liver radioactivity in relation to quality and fate of phosphate complexes with technetium-99m. Nucl.-Med 1976; XV: 95-96.
- 75 Huberty J. P. Long shelf-life of 99mTc-MAA lung particle kits. J. nucl. Med 1974; 15: 464.
- 76 Huberty J. P, Hattner R. S, Powell M. R. A 99mTc-pyro-phosphate kit: a convenient, commercial and high quality skeletal imaging agent. J. nucl. Med 1974; 15: 124-126.
- 77 Hurley P. J. Organ visualization and related studies - clinical value. In: Recent Advances in Clinical Nuclear Medicine-1. Eds.: W. R. Greig, F. C. Gillespie. Churchill Livingstone, London 1975, pp. 59-105.
- 78 Ikeda I, Inoue O, Kurata K. A new preparation method for 99mTc-phytate. J. nucl. Med 1976; 17: 389-393.
- 79 Ikeda I, Inoue O, Kurata K. Chemical and biological studies on 99mTc-DMS. II. Effect of Sn(II) on the formation of various Tc-DMS complexes. Int. J. appl. Radiat 1976; 27: 681-688.
- 80 Ikeda I, Inoue O, Uchida J, Sugisawa Y, Kurata K, Kato S. A simple, rapid and effecient preparation of 99mTd compounds by electrolysis. (IV) 99mTc-tetracycline. Radioisotopes (Tokyo) 1974; 23: 551-556.
- 81 Jeyasingh K, Glass H. I. Preparation of 99mTc-iron ascorbic acid complex for kidney scanning. Int. J. appl. Radiat 1970; 21: 238-239.
- 82 Jones A. G, Davis M. A, Dewanjee M. K. 113mIn-labelled bone scanning agents. Radiology 1975; 17: 727-730.
- 83 Kaplan S. A, Jack M. L. Utility of bioavailability studies in drug development. Drug Develop, and ind. Pharmacy 1977; 3: 39-64.
- 84 Kaplan W. D, Holman B. L, Liebow P. A, Davis M. A. Enhanced detection of a skeletal lesion with delayed 99mTc-polyphosphate bone scanning. J. nucl. Med 1974; 15: 47-49.
- 85 Khentigan A, Garrett M, Lum D, Winchell H. S. Effects of prior administration of Sn(II) complexes on in vivo distribution of 99mTc-pertechnetate. J. nucl. Med 1976; 17: 380-384.
- 86 Klingensmith III W. C., Tsan M, Wagner Jr. H. N.. Factors affecting the uptake of 99mTc-sulfur colloid by the lung and kidney. J. nucl. Med 1976; 17: 681-684.
- 87 Krejcarek G. E, Wicks J. H, Heerwald P. E, Tucker K. L, Kubik V.M, Newmark R. A, Williams R. C. The structure of stannous dimercaptosuccinic acid chelates. J. nucl. Med 1976; 17: 565.
- 88 Krishnamurthy G. T, Huebotter R. J, Tubis M, Bland W. H. Pharmaco-kinetics of current skeleton-seeking radiopharmaceuticals Amer. J. Roentgenol 1976; 126: 293-301.
- 89 Krishnamurthy G. T, Tubis M, Endow J. S, Singhi V, Walsh C. F, Blahd W. H. Clinical comparison of the kinetics of 99mTc-labelled polyphosphate and diphosphonate. J. nucl. Med 1974; 15: 848-855.
- 90 Kristensen K, Pederson B. Lung retention of 99mTc-sulfur colloid. J. nucl. Med 1975; 16: 439-440.
- 91 Krogsgaard O. W. Radiochemical purity of various 99mrelabelled bone-scanning agents. Eur. J. nucl. Med 1976; 12: 15-17.
- 92 Kubota H, Eckelman W. C, Poulose K. P, Reba R. C. Technetium-99m-pyridoxylidene glutamate, a new agent for gall bladder imaging: comparison with 131I-Rose Bengal. J. nucl. Med 1976; 17: 36-39.
- 93 Kuperus J, Lyons K. P. Chromatography of 99mTc-labelled radiopharmaceuticals. J. nucl. Med 1977; 18: 494-495.
- 94 Larson S. M, Nelp W. B. Radiopharmacology of a simplified technetium-99m-colloid preparation for photoscan-ning. J. nucl. Med 1966; 7: 817-826.
- 95 Lin T. H, Khentigan A, Winchell H. S. A 99mTc-chelate substitute for organoradiomercurial renal agents. J. nucl. Med 1974; 15: 34-35.
- 96 Lin T. H, Khentigan A, Winchell H. S. A 99mTc-labelled replacement for 131I-Rose Bengal in liver and biliary tract studies. J. nucl. Med 1974; 15: 613-615.
- 97 Loberg M. D, Cooper M, Harvey E, Callery P, Faith W. Development of new radiopharmaceuticals based on N-sub-stitution of iminodiacetic acid. J. nucl. Med 1976; 17: 633-638.
- 98 Lyons K. P, Kuperus J, Glenn H. W. Localization of Tc-99m pyrophosphate in the liver due to massive liver necrosis. J. nucl. Med 1977; 18: 550-552.
- 99 Lyster D. M, Scott J. R, Mincey E. K, Morrison R. T. Preparation of a 99mTc-Sn-MAA kit for use in nuclear medicine. J. nucl. Med 1974; 15: 198-199.
- 100 Mazzola A. L, Barker M. H, Belliveau R. E. Accumulation of 99mTc-diphosphonate at sites of intramuscular iron therapy. J. nucl. Med. Tech 1976; 4: 133-135.
- 101 McCormick M. V, Sinclair M. D, Wahner H. W. Chromatographic quality of three 99mTc bone-imaging agents. J. nucl. Med. Tech 1976; 4: 189-192.
- 102 McKusick K. A, Mahmud L. S, Kirchner P. T. An interesting artifact in radionuclide imaging of the kidneys. J. nucl. Med 1973; 14: 113-114.
- 103 McLean J. R, Wise P. Impurities in a 99mTc-lung imaging kit. J. nucl. Med. Tech 1977; 5: 28-31.
- 104 McRae J, Hambright P, Valk P, Bearden A. J. Chemistry of 99mTc-tracers II. In vitro conversion of tagged HEDP and pyrophosphate (bone seekers) into gluconate (renal agent)
- 104 Effects of Ca, Fe(II) on in vivo distribution. J. nucl. Med. 1976; 17: 208-211.
- 105 McRae J, Singer R. M, Shipley B, Hook G. R. Alterations in tissue distribution of 99mTc-pertechnetate in rats given stannous tin. J. nucl. Med 1974; 15: 151-155.
- 106 Merlin L. Use and benefits of kits. In: Radiopharmaceuticals from Generator-Produced Radionuclides. Proceedings of a Panel. IAEA: Vienna; 1971: 145-148.
- 107 Merlin L, Besnard M, Cohen Y. Chimie du Technetium: Influence des systems oxyreducteurs sur la stabilite des complexes utilises come radiopharmaceutiques. In: Radiopharmaceuticals and Labelled Compunds. Proceedings of a Symposium. Vol. I.. IAEA: Vienna; 1973: 63-70.
- 108 Mikhael M. A, Evens R. G. Migration and embolization of macrophages to the lungs - a possible mechanism for colloid uptake in the lung during liver scanning. J. nucl. Med 1975; 16: 22-27.
- 109 Monroe L. A, Thompson W. L, Anderton N. S, Burdine J. A. Evaluation of an improved 99mTc-Sn-aggregated albumin preparation for lung imaging. J. nucl. Med 1974; 15: 192-194.
- 110 Narashiman D. V. S, Mani R. S. Electrolytic preparation of 99mTc-human serum albumin using tin electrodes. Radio-chem. Radioanal. Lett 1975; 20: 307-316.
- 111 Nelson M. F, Melton R. E, Van Wazer J. R. Sodium trimeta phosphate as a bone-imaging agent. I. Animal Studies. J. nucl. Med 1975; 16: 1043-1048.
- 112 Nolan N. G. Intense uptake of 99mTc-diphosphonate by an extraosseous neurofibroma. J. nucl. Med 1974; 15: 1207-1208.
- 113 Noronha O. P. D, Sewatkar A. B, Ganatra R. D. Factors affecting the preparation of 99mTc-sulfur solloid. Eur. J. nucl. Med 1978; 3: 47-54.
- 114 Noronha O. P. D, Sewatkar A. B, Ganatra R. D, Glenn H. J. An alternate approach to the preparation of 99mTc-sulfur colloid. Int. J. nucl. Med. Biol 1975; 2: 184-185.
- 115 Noronha O. P. D, Sewatkar A. B, Ganatra R. D, Subramanian G. 99mTc-pyridoxylidene glutamate - a radiopharmaceutical for the hepatobiliary system. Nucl.-Med 1976; XV: 71-74.
- 116 Noronha O. P. D, Sewatkar A. B, Ganatra R. D, Subramanian G. The transport, hepatobiliary distribution and clearance of 99mTc-Sn-lidocaine iminodiacetic acid, 99mTc-Sn-LIDA. Int. J. nucl. Med. Biol 1977; 4: 122-128.
- 117 Owunwanne A, Church L. B, Blau M. Effect of oxygen on the reduction of pertechnetate by stannous ion. J. nucl. Med 1977; 18: 822-826.
- 118 Owunwanne A, Weber D. A, O’Mara R. E. Radiochemical analysis of radiopharmaceuticals. The technetium-99m phosphorus compounds. J. nucl. Med 1977; 18: 637.
- 119 Panek K, Dienstbier Z, Raban P. Radioactive pharmaceuticals used in diagnostics. In: Radionuclides in Pharmacology, Vol. II (IEPT). Eds Cohen Y.. Pergamon Press; Oxford: 1971: 753-843.
- 120 Pauwels E. K. J, Feitsma R. I. J. Radiochemical quality control of 99mTc-labelled radiopharmaceuticals. Eur. J. nucl. Med 1977; 2: 97-103.
- 121 Pavel D. G, Zimmer A. M, Patterson V. N. In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization. J. nucl. Med 1977; 18: 305-308.
- 122 Platthy A, Shah U. False positive scintigrams due to malposition of liver. J. nucl. Med 1974; 15: 717-719.
- 123 Porter W. C, Dworkin H. J, Gutkowski R. F. The effect of carrier technetium in the preparation of 99mTc-human serum albumin. J. nucl. Med 1976; 17: 704-706.
- 124 Potsaid M. S, Guiberteau M. J, McKusick K. A. Quality of bone scans compared with time between dose and scan. J. nucl. Med 1977; 18: 787-789.
- 125 Robbings P. J, Fortman D. L, Lewis J. T. A new lung scanning agent: 99mTc(Sn)MAA. Int. J. appl. Radiat 1973; 24: 48183.
- 126 Robinson Jr. G. D., Battaglia D. J. Technetium-99m-te- tracycline: preparation, biological dynamics and uptake in damaged and normal skeletal muscle. Int. J. appl. Radiat 1975; 26: 147-152.
- 127 Rollo F. D, Cavalieri R. R, Born M, Blei L, Chew M. Comparative evaluation of 99mTcGH, 99mTcO4 and 99mTcDTPA as brain imaging agents. Radiology 1977; 123: 379-383.
- 128 Schümichen C, Nakken K. F. A comparison of the bone seeking properties of short-chained 99mTc-Sn-polyphospha-tes. Nucl.-Med 1974; XIII: 139-143.
- 129 Schümichen C, Rorvick-Schümichen K, Hoffman G. 99mTc-Sn-pyrophosphate complexes, an investigation of its possible structures. Nucl.-Med 1974; XIII: 252-257.
- 130 Sewatkar A. B, Noronha O. P. D, Ganatra R. D. On the stability of a Sn-phytate complex. Nucl.-Med 1975; XIV: 293-297.
- 131 Sewatkar A. B, Noronha O. P. D, Ganatra R. D, Glenn H. J. Some aspects of the radiopharmaceutics of 99mTc- phytate. Nucl.-Med 1975; XIV: 46-51.
- 132 Sewatkar A. B, Subramanian G, McAfee J. G, Rosenstreich M, Henderson R. W. A new solid phase reduction system using insoluble stannous salts for the preparation of 99mTc labeled radiopharmaceuticals. Presented at 15th International Annual Meeting of the Society of Nuclear Medicine. Gronigen; Netherlands: Sept 1977: 13-16.
- 133 Silberstein E. B. Calcium, phosphorus and 99mTc “uptake”. J. nucl. Med 1974; 15: 918.
- 134 Skelly J. P. Bioavailability and bioequivalence. J. clin. Pharmacol 1976; 16: 539-545.
- 135 Smith T. D, Richards P. A simple kit for the preparation of 99mTc-labelled red blood cells. J. nucl. Med 1976; 17: 126-132.
- 136 Stebner F. C. Steroid effect on the brain scan in a patient with cerebral metastases. J. nucl. Med 1975; 16: 320-325.
- 137 Steigman J, Richards R. Chemistry of technetium-99m. Sem. Nucl. Med 1974; 4: 269-279.
- 138 Stelmach H. A, Quinn J. L.. III Radiopharmaceutical quality control. Sem. Nucl. Med 1974; 4: 295-303.
- 139 Steinman S. Reply to “Impurities in a 99mTc-lung imaging kit”. J. nucl. Med. Tech 1977; 5: 55-56.
- 140 Stern H. S, McAfee J. G, Subramanian G. Preparation, distribution and utilization of technetium-99m-sulfur colloid. J. nucl. Med 1966; 7: 665-675.
- 141 Srivastava S. C, Meinken G, Smith T. D, Richards P. Problems associated with stannous 99mTc-radiopharmaceu-ticals. Int. J. appl. Radiat 1977; 28: 83-95.
- 142 Subramanian G, Chander J, Singh M. V, Dham D. N, Lakshmipathi N, Singh B. A new radiopharmaceutical for gall bladder studies. Nucl.-Med 1977; XVI: 83-85.
- 143 Subramanian G, McAfee J. G, Bell E. G, Blair R. J, O’Mara R. E, Ralston P. H. 99mTc-labelled polyphosphate as a skeletal imaging agent. Radiology 1972; 102: 701-704.
- 144 Subraminian G, McAfee J. G, Blair R. J, Mehter A, Connor T. 99mTc-EHDP: A potential radiopharmaceutical for skeletal imaging. J. nucl. Med 1972; 13: 947-950.
- 145 Subramanian G, McAfee J. G, Blair R. J, Rosen-streich M, Coco M, Duxbury C. E. Technetium-99m labelled stannous imidophosphate, a new radiodiagnostic agent for bone scanning: Comparison with other complexes. J. nucl. Med 1975; 16: 1137-1143.
- 146 Subramanian G, McAfee J. G, Blair R. J, Thomas F. D. Radiopharmaceuticals for bone and bone-marrow imaging - a review. In: Medical Radionuclide Imaging Vol. II. Proceedings of a Symposium. IAEA; Vienna: 1977: 83-104.
- 147 Subramanian G, McAfee J. G, Henderson R, Rosen-streich M. New bifunctional chelates for designing Tc-99m labelled radiopharmaceuticals. In: Proceedings of First Asia and Oceania Congress of Nuclear Medicine. Sydney; Australia: 1976: 144-149.
- 148 Subramanian G, McAfee J. G, Emhter A, Blair R. J, Thomas F. D. 99mTc-stannous phytate: a new in-vivo colloid for imaging the reticuloendothelial system. J. nucl. Med 1973; 14: 459.
- 149 Sy W. M, Westring D. W, Weinberger G. “Cold” lesions on bone imaging. J. nucl. Med 1975; 16: 1013-1016.
- 150 Taplin G. V. The scintillation scan. In: Clinical Scintillation Scanning. Eds Freeman L. H, Johnson P. M.. Harper & Row; New York: 1969: 119
- 151 Tofe A. J, Francis M. D. Optimization of the ratio of stannous tin: ethane-l-hydroxy-1, 1-diphosphonate for bone scanning with 99mTc-pertechnetate. J. nucl. Med 1974; 15: 69-74.
- 152 Tofe A. J, Francis M. D. In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid. J. nucl. Med 1976; 17: 820-825.
- 153 Trumper Y, Weininger J, Lubin E. 99mTc-pyridoxylidene glutamate kit: A rapid cholescintigraphic agent. Int. J. nucl. Med. Biol 1976; 3: 45-48.
- 154 Valk P. E, Dilts C. A, McRae J. A possible artifact in gel chromatography of some 99mTc-chelates. J. nucl. Med 1973; 14: 235-237.
- 155 Vanlic-Razumenic N. M, Gorkic D. A. Studies of chemical and biological properties of 99mTc-DMS (dimercaptosuc-cinic acid) - renal imaging agent. Eur. J. nucl. Med 1976; 1: 235-242.
- 156 Vieras F, Boyd C. M. Diagnostic value of renal imaging incidental to bone scintigraphy with 99mTc-phosphate compounds. J. nucl. Med 1975; 16: 1109-1114.
- 157 Wagner Jr. H. N.. The search of magic bullets. In: Radiopharmaceuticals Eds Subramanian G, Rhodes B. A, Cooper J. F, Sodd V. J.. Soc. Nucl Med. Inc.; New York: 1975: XIII-XV.
- 158 Wagner Jr. H. N.. et al. The lung and The gastrointestinal tract, liver and pancreas. In: Principles of Nuclear Medicine Ed. Wagner Jr. H. N.. Philadelphia: W. B. Saunders Co.,; 1969: 472-530. And 548-627
- 159 Waxman A. D, Tanaceseu D, Siemsen J. K, Wolf-stein R. S. Technetium-99m glucoheptonate as a brain-scanning agent: Critical comparison with pertechnetate. J. nucl. Med 1976; 17: 345-348.
- 160 Webber M. M. Affinity of fibrin deposits for Tc-sulfur colloid. J. nucl. Med 1976; 17: 940.
- 161 Weiss S, Conway J. J. Bone imaging artifacts. J. nucl. Med. Tech 1977; 5: 17-22.
- 162 Winchell H. S. Effect of tin-reduced enzymes on pertech-netate distribution, J. nucl. Med 1976; 17: 941-942.
- 163 Winston M. A, Halpern S. E, Weiss E. R, Endow J. S, Blahd W. H. A critical evaluation of 99mTc-Fe-ascorbic acid complex as a renal scanning agent. J. nucl. Med 1971; 12: 171-175.
- 164 Winter P. F, Perl L. J, Johnson P. M. Lung uptake of colloid during liver-spleen scanning: a normal finding in children. Nucl.-Med 1976; XV: 294-296.
- 165 Yakoyama A, Saji H, Tanaka H, Odori T, Morita R, Mori T, Torizuka K. Preparation of a chemically characterized 99mTc-penicillamine complex. J. nucl. Med 1976; 17: 810-815.
- 166 Yano Y. Radionuclide generators: Current and future applications in nuclear medicine. In: Radiopharmaceuticals. Eds. Subramanian G, Rhodes B. A, Cooper J. F, Sodd V. J.. Soc. Nucl. Med. Inc; New York: 1975: 236-245.
- 167 Yano Y, Anger H. O, McRae J, Honbo D. Lung scanning with technetium-99m ferric hydroxide macroag-gregates. In: Radiopharmaceuticals from Generator-Produced Radionuclides. Proceedings of a Panel. I.A.E.A.; Vienna: 1971: 59-65.
- 168 Yano Y, Chu P, Anger H. O. Tin-117m: production, chemistry and evaluation as a bone scanning agent. Int. J. appl. Radiat 1973; 24: 319-325.
- 169 Ziessman H. A. Lung uptake of 99mTc-sulfur colloid in falciparum malaria. J. nucl. Med 1976; 17: 794-796.
- 170 Zimmer A. M, Holmes R. A. A precise chromatographic system for specific technetium-99m radiopharmaceuticals. Nucl.-Med 1975; XV: 192-195.
- 171 Zimmer A. M, Isitman A. T, Holmes R. A. Enzymatic inhibition of diphosponate: dis-phosphonate: A proposed mechanism of tissue uptake. J. nucl. Med 1975; 16: 352-356.
- 172 Zimmer A. M, Pavel D. G. Radiochemical evaluation and image correlation of stabilized and non stabilized 99mTc-Sn disphosphonate kits. J. nucl. Med. Tech 1977; 5: 54-55.